However, the U.S. market is a mystery, and you only know the San Francisco Bay and Boston areas. Other major U.S. cities are prime setup locations for femtech companies looking to enter the market.
With our support, you will have confidential connections in three U.S. regions who will roll out the red carpet!
If you are an innovative medtech company considering entering the U.S. market, you will typically be directed towards the San Francisco Bay and Boston areas. However, other major cities can also offer all the support needed to professionalize and structure the export process, but at a fraction of the cost. New market entry is risky and expensive, and you want to operate with trusted actors!
On our mission, participants learn about and have privileged contact with three distinct geographic areas of the U.S.:
Established life science ecosystem.
Femtech innovation and visibility hub.
A vibrant and growing life science and tech ecosystem.
Participants will meet local ecosystem actors, have discussions with potential scientific and academic partners, and learn about the financial incentives available.
Startups, Scaleups, SMEs
Femtech Domain: SAAS, hardware, platforms
Femtech Founders & CEOs, Healthcare Professionals, Researchers, Women's Health advocates
Ready to enter the U.S. market in the next 1–2 years
This mission will provide you with the information needed to decide where to set up your U.S. operations and/or distribution. You need a secure location from which to operate, surrounded by trusted experts who can guide your market entry.
Visualize your U.S. network!
With the support of local ecosystem actors, you will discover the complexities of the U.S. market and how to position your product or service for a successful market entry. Create your network of U.S. partners and collaborators by meeting significant actors in the U.S. medtech ecosystem, including healthcare professionals, patients, payers, medtech accelerators and others.
North America held a commanding 38.64% share of the global FemTech market in 2024. The global FemTech Market is projected to reach US$ 266.99 billion by 2035.
Phoenix is the 5th largest city in the U.S. Arizona's bioscience companies attracted strong venture capital investment. Arizona State University (ASU) is one of the fastest-growing research institutions in the country.
The European (French, Swiss, others)-U.S. Chambers of Commerce are very active in the three regions.
The Research Triangle in North Carolina is a perfect mix with a vast talent pool, a very reasonable cost of living, and direct connections to Europe. Duke University Hospital is ranked among the nation's best by U.S. News & World Report
The Southwest U.S. and North Carolina are among the fastest-growing U.S. regions and attract diverse and internationally connected populations.
Southern California serves as the FemTech innovation and visibility hub, combining diverse patient populations, leading women's health providers, and investor density.
You will need to book 2 flights:
May 2026
Leave Europe (direct flights from CDG or LHR to Raleigh-Durham airport(RDU)
RESEARCH TRIANGLE PARK
Possible visits: Duke University Hospital, Pinkubator, North Carolina Biotech Center
Evening: Reception with local ecosystem actors
First Flight Venture Center
NC Biotech
SOUTHERN CALIFORNIA
Flight to LAX
Possible visits: HOAG Hospital, UC Irvine Hospital, Scribbs San Diego, UC San Diego
KOL Reception
round tables: clinical trials, FDA
flight to PHX
PHOENIX
Venture Cafe
Visits: Mayo Clinic, Medtech Accelerator, Medtronic, Phoenix Bioscience Core ASU Scottsdale Innovation Center, Thunderbird School of Global Management
Leave PHX
Arrival Europe
Renée MEYER creates bridges between Europe and the U.S., linking ecosystems in the medical space, with a special focus on the U.S. Mid- and Southwest. She accompanies medtech SMEs and startups in their transition to the U.S. market.
As a multilingual American citizen from Ohio, Renée lives in the tri-country region near Strasbourg France. She has lived in Europe for over 25 years, leading projects in finance, sustainability and intercultural communication, while working for international pharmaceutical companies and NGOs in Switzerland and France. Renée travels frequently to the U.S., which allows her to keep a constant eye on the evolution of U.S. corporate culture, and the differences between regions within the country. Renée organises visits with U.S. EDOs to Strasbourg, while structuring numerous programs in collaboration with Chambers of Commerce, industry associations, accelerators and universities.
is a U.S. Market-Entry and Expansion accelerator program for Europe's most promising growth-stage companies, leveraging Southern California as the Strategic Gateway to the American Market. TAVA provides deep immersion, top-tier expertise and a structured, credential-driven pathway to ensure scalable and sustainable U.S. Growth. TAVA's programs combine access, expertise, and immersion, the three elements required for a successful scale-up into one of the world's most competitive markets.
Built in partnership with leading academic institutions, investors, industry experts, and a growing network of service partners, TAVA provides a structured, risk-optimized, high-impact pathway for companies ready to internationalize.
Have questions about the mission or ready to join? Reach out to us!